Non-Dilutive Funding:
9 Ways to Grow Without Giving Up Equity

Short answer

Non-dilutive funding lets startups raise capital without selling equity. The main options are government grants (SBIR, EIC Accelerator), R&D tax credits, venture debt, revenue-based financing, invoice factoring, inventory financing, bank and SBA loans, customer prepayments and rewards crowdfunding. Each is priced against a different asset — your research, revenue, receivables or stock — not your cap table.

Equity is the most expensive money you will ever raise. A 20% seed stake in a company that exits at €50 million ends up costing €10 million — for a cheque that was maybe €1.5 million at the time. Yet many founders treat dilution as the default and everything else as exotic. This guide covers nine non-dilutive funding options, what each genuinely costs, and one rule for choosing between them.

The market has voted with its wallet. US venture debt hit a record $68.8 billion in 2025, according to PitchBook's 2025–2026 Venture Debt Review, and The Business Research Company sizes revenue-based financing at roughly $9.8 billion in 2025. Capital that doesn't touch the cap table is no longer a niche.

What are the non-dilutive funding options for startups?

Non-dilutive vs dilutive funding comes down to one question: does the money buy shares? If yes — angels, VC, crowdequity — your ownership shrinks. If no, you keep the company and pay in something else: interest, a revenue share, fees or paperwork.

The nine options below fall into four families: free money (grants, tax credits), borrowed money (venture debt, bank loans), revenue-priced money (RBF, factoring, inventory finance) and customer money.

The nine ways, one by one

1. US federal R&D grants: SBIR and STTR

America's Seed Fund is the largest single pool of free startup money in the world: the 11 participating agencies award roughly $4 billion a year, per the Congressional Research Service. After the April 2026 reauthorization, Phase I awards run to about $323,000 and Phase II to roughly $2.15 million — no equity, no repayment. The catch is time: months from application to money, plus real reporting duties. We break down eligibility and the 2026 changes in SBIR grants explained.

2. EU and German grant programmes

The European Commission's EIC Accelerator combines a grant of up to €2.5 million with an optional equity component, from a €634 million budget in 2026. Acceptance is brutal but the money is transformative for deep tech — see EIC Accelerator grant amounts and odds. German founders coming out of university can add the EXIST founder stipend, which covers living costs and material expenses for the first year. Regional programmes from the federal states stack on top.

3. R&D tax credits: money you already earned

The most underused option because it looks like accounting, not fundraising. In the US, a qualified small business — under $5 million in gross receipts — can offset up to $500,000 of R&D credit against payroll taxes each year, even with zero profit, per IRS rules under Section 41. Germany's Forschungszulage refunds 25% of eligible R&D costs, 35% for SMEs, and pays out in cash even if you're loss-making. Both are retroactive claims on money you already spent. Start here.

4. Venture debt

A term loan for VC-backed startups, typically sized at 20–35% of your last equity round, at 8–15% interest plus warrants worth roughly 0.5–2% of equity. PitchBook's data shows SaaS borrowers alone took more than $28 billion in 2025. It shines when it buys the two extra quarters that get you to a milestone — and hurts when it substitutes for a round you couldn't raise. Full mechanics in how venture debt works and when to use it.

5. Revenue-based financing (RBF)

An advance repaid as a fixed slice of monthly revenue — usually 5–15% — until you've paid back an agreed multiple, typically 1.3–1.5x. No warrants, no board seat, fast underwriting from your actual revenue data. The multiple hides an effective interest rate that rises the faster you repay, which is why we wrote a whole piece on the real cost of revenue-based financing.

6. Invoice factoring and receivables finance

If your customers pay on 30–90 day terms, your balance sheet is lending them money for free. Factoring flips that: a finance company advances 70–90% of the invoice face value now and takes a fee of roughly 1–3% per 30 days outstanding. Expensive as annualised interest, cheap as a bridge — and it scales automatically with sales. Best for B2B companies with creditworthy customers and painful payment terms.

7. Inventory and purchase-order financing

DTC and e-commerce brands die in the gap between paying the manufacturer and getting paid by the customer. Inventory financing funds the stock order itself, with repayment timed to the sales it generates. Fees are charged per funded order rather than as headline interest, so read the terms twice. We cover the options in how DTC brands finance inventory.

8. Bank loans and SBA-guaranteed loans

Boring, slow and cheap. In the US, SBA 7(a) loans run up to $5 million with the government guaranteeing most of the lender's risk; in Germany, KfW-backed founder loans play a similar role through your house bank. Expect collateral requirements, covenants and — for smaller companies — personal guarantees. Banks fund history, not projections, so this lane opens properly once you have two years of accounts and positive cash flow in sight.

9. Customer funding: the cheapest capital nobody models

Annual prepay at a 10–15% discount, multi-year deals invoiced upfront, paid pilots, licensing deals, pre-orders and rewards crowdfunding — every one of these is your customer financing your growth. The cost is a discount and a delivery obligation, not interest or equity. A SaaS moving half its base from monthly to annual billing can pull an entire quarter of collections forward. Before pricing any external capital, price this.

How do you choose? Match the money to the asset that repays it

Here's what most founders get wrong: they pick non-dilutive funding by availability — whoever says yes first — instead of matching each source to the thing it's secured against. That mismatch is how cheap-looking money becomes expensive.

A four-line decision framework:

1. Fund R&D with grants and tax credits. Research has no revenue to share and no collateral to pledge. Free money is the only money that fits it.
2. Fund working capital with revenue-priced money. Factoring, inventory finance and RBF repay themselves from the exact cash cycle they finance.
3. Fund runway extension with venture debt — only alongside equity. Debt sized off a fresh round extends it; debt replacing a failed round accelerates the ending.
4. Fund growth experiments with customer cash first. If customers won't prepay, discount or pre-order, that's information about the experiment.

The rule underneath: never use short-term expensive money for long-term bets, and never sell permanent equity to fix a temporary timing gap.

What this means for you

Sequence matters more than selection. Claim R&D tax credits first — they're retroactive and near-certain. File grant applications early, because decisions take six months or more. Line up venture debt in the months right after a round closes, when your negotiating position peaks. And keep every obligation documented: revenue shares and debt that surface unannounced in due diligence cost more trust than money.

A blended stack — one grant, one credit, one revenue-priced line — routinely replaces a third of the next round. On a typical seed, that's several points of ownership that stay yours.

Frequently asked questions

Is non-dilutive funding really cheaper than equity?

Usually, yes — if your company grows. Equity has no interest rate, but a 20% stake in a startup that exits at $50M costs $10M. Grants cost only time; debt costs 8–15% interest; RBF costs a 1.3–1.5x cap. Equity only wins when the outcome is highly uncertain and you need patient capital with no repayment obligation.

Can you combine non-dilutive funding with a VC round?

Yes, and most funded startups do. Venture debt is typically raised within months of an equity round and sized at 20–35% of it. Grants and R&D tax credits stack on top of any round, and investors generally read them as a positive signal. Just disclose everything — undisclosed debt or revenue-share obligations surface in due diligence.

How much non-dilutive funding can an early-stage startup realistically get?

A US deep-tech startup can reach roughly $2.5M through SBIR Phase I and II alone, plus up to $500K a year in R&D payroll tax credits. An EU startup can combine an EIC Accelerator grant of up to €2.5M with national programmes like Germany's Forschungszulage. Revenue-priced options scale with traction, typically 3–12x monthly revenue.

Does venture debt count as non-dilutive?

Mostly. The loan itself buys no shares, but lenders usually take warrants worth around 0.5–2% of fully diluted equity. That is a fraction of the 15–25% sold in a typical priced round, so venture debt is conventionally grouped with non-dilutive options — 'low-dilutive' is the more honest label.

Sources

1. PitchBook — AI and a new scale of startups took US venture debt funding to another record, 2026. https://pitchbook.com/news/articles/ai-and-a-new-scale-of-startups-took-us-venture-debt-to-a-record
2. The Business Research Company — Revenue-Based Financing Global Market Report, 2025. https://www.thebusinessresearchcompany.com/report/revenue-based-financing-global-market-report
3. European Commission — EIC Accelerator, 2026. https://eic.ec.europa.eu/eic-funding-opportunities/eic-accelerator_en
4. IRS — Qualified small business payroll tax credit for increasing research activities, 2026. https://www.irs.gov/businesses/small-businesses-self-employed/qualified-small-business-payroll-tax-credit-for-increasing-research-activities
5. Congressional Research Service — Small Business Research Programs: SBIR and STTR, 2025. https://www.congress.gov/crs-product/R43695